Calviri’s mission is to provide affordable products worldwide that will end deaths from cancer.  They are a fully integrated healthcare company developing a broad spectrum of vaccines and companion diagnostics that prevent and treat cancer for those either at risk or diagnosed.  They focus on using frameshift neoantigens derived from errors in RNA processing to provide pioneering products against cancer. 

Biotechnology

Calviri

Marc Wolff

Alexandra Kassis

Nikolina Nikolic

Terrence O’Neil

Kathryn Sykes

Calviri's Board of Directors includes Michael Chambers and 3 others.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Calviri

Leadership Team

CEO and Executive Team